Trial | NCT02228746  Report issue

Official Title

Effect of the Alpha-galacto-oligasaccharides on Weight Loss in Overweight or Moderately Obeses Adults : A Randomized Controlled Double Blinded Trial Versus Placebo

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    100
Clinical intervention on overweight or moderately obeses adults. The objective of this trial is to demonstrate the superior eficacy of Alphagos to placebo on weight loss during a low-calorie diet of 12 weeks. The superiority is judged on body weight. Change in cardiometabolic risk factors through the intervention have been evaluated as secondary endpoints
Study Started
Sep 30
2013
Primary Completion
Aug 31
2014
Study Completion
Aug 31
2014
Last Update
Aug 29
2014
Estimate

Dietary Supplement Alpha-galacto-oligosaccharides

6g of alpha-galacto-oligosaccharides in a 100 mL flavored drink

Alpha-galacto-oliosaccharides Experimental

Placebo Placebo Comparator

Criteria 

Inclusion Criteria:

Body Mass Index > or equal 25 and < 35
Use of effective contraception in women of childbearing age

Exclusion Criteria:

Pregnant women (positive pregnancy test) or breastfeeding
Anti-hypertensive or cholesterol treatment
HIV infection or HCV
Hepatic and/or severe renal failure
Heart attack within 6 months prior the selection
Heart failure known
Inflammatory disease known
Cancer or have had cancer within 3 years prior to the study except for basal cell skin cancers
Diabetes defined by blood glucose greater than or equal to 1.26 g/L
Gastrointestinal disease known
Bariatric surgery
No Results Posted